Articles By Eric Larson

  1. FDA RIFs Might Delay Your Review — Here Are Tips For Mitigating 4/24/2025

    Mounting concerns that FDA reviewers could start missing PDUFA deadlines have put many on edge. The moment calls for defensive and offensive strategies.

  2. 04.24.25 -- The Latest Developments And Challenges With EU Medical Devices Legislation 4/24/2025
    04/24/25 Med Device Online Newsletter
  3. EC Rep To EU Rep: The Symbol Shift You Can't Ignore 4/23/2025

    The recent update to ISO 15223-1, formalized through Amendment 1:2025, ushers in a critical shift for medical device labeling from the legacy “EC REP” symbol to a more flexible, jurisdiction-specific format: “XX-REP.”

  4. Simplifying System Architecture For Ambulatory Blood Pressure Monitoring 4/23/2025

    Integrating a disc pump enabled the creation of a compact, quiet, arm-worn ABPM device that improved measurement accuracy, patient comfort, and simplified system architecture.

  5. Solenoid Valve Performance Trade-Offs And Design Challenges 4/23/2025

    Solenoid valve design involves complex trade-offs between pressure, flow, leakage, temperature, and material. Adjusting one feature often impacts others, requiring careful engineering balance.

  6. 5 Common Solenoid Valve Failure Modes 4/23/2025

    Solenoid valve performance depends on proper design, installation, maintenance, and contamination prevention. Common failure modes include pressure issues, electrical faults, and improper system compatibility.

  7. 04.22.25 -- Risk Management Planning: Be Prepared When Disaster Strikes 4/22/2025
    04/22/25 Med Device Online Newsletter
  8. 04.20.25 -- HLA Typing For HSCT: New Research Indicates Expanded Patient Compatibility 4/20/2025

    04/20/25 Med Device Online Newsletter

  9. 04.17.25 -- The Future Of Medical Device Labeling Is Here 4/17/2025
    04/17/25 Med Device Online Newsletter
  10. A Proactive 6-Point Approach To Security For Neurotech Developers 4/17/2025

    There are several key security concerns neurotech developers must address from the outset to ensure both medical and ethical compliance, as well as commercial success.